Corteria Pharmaceuticals
FranceEntry
2023
Hold
3yr
Status
Active
Who owns Corteria Pharmaceuticals?
Corteria Pharmaceuticals is a French Biotech company, currently owned by Jeito Capital since 2023 and 2 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2021 · present
Omnes CapitalActive
2021 · present(5yr) · Omnes Real Tech 1 · 2018 · VC
Invivo PartnersActive
2021 · present(5yr) · Invivo Ventures · 2019 · Life Sciences VC
Jeito CapitalActive
2023 · present(3yr) · Jeito I · 2021 · VC
More from Jeito I
Other portfolio companies in the same fund.
Switzerland
Spain
Germany
US
DenmarkMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Corteria Pharmaceuticals?
Corteria Pharmaceuticals is currently owned by Jeito Capital, Omnes Capital and 1 other, through Jeito I, since 2023.
When did Jeito Capital and 2 others acquire Corteria Pharmaceuticals?
Jeito Capital and 2 others acquired Corteria Pharmaceuticals in 2023.
Who has owned Corteria Pharmaceuticals over time?
Corteria Pharmaceuticals has been through 3 private-equity ownership periods: Omnes Capital · via Omnes Real Tech 1 · since 2021; Invivo Partners · via Invivo Ventures · since 2021; Jeito Capital · via Jeito I · since 2023.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue